Hjem
Anders Engelands bilde
Foto:
Private
  • E-postanders.engeland@uib.no
  • Telefon+47 55 58 61 2797018094
  • Besøksadresse
    Årstadveien 17
    Blokk D
    5020 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen

Legemiddelepidemiologi

Kreftepidemiologi

Livsstilsepidemiologi

Forbedret prognose til pasienter med glioblastom (GlioLink prosjektet)

 

  • Veileder medisinerstudenter (særoppgave) og PhD studenter
  • Vis forfatter(e) (2022). Labor epidural analgesia and subsequent risk of offspring autism spectrum disorder and attention-deficit/hyperactivity disorder: A cross-national cohort study of over 4.5 million individuals and their siblings. American Journal of Obstetrics and Gynecology. 12 sider.
  • Vis forfatter(e) (2022). Interaction of leisure-time physical activity with body mass index on the risk of obesity-related cancers: A pooled study. International Journal of Cancer. 1-10.
  • Vis forfatter(e) (2022). Association between medical androgen deprivation therapy and long-term cardiovascular disease and all-cause mortality in nonmetastatic prostate cancer. International Journal of Cancer. 1109-1119.
  • Vis forfatter(e) (2021). Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia. Acta Obstetricia et Gynecologica Scandinavica. 2111-2118.
  • Vis forfatter(e) (2021). The Norwegian Society for Pharmacoepidemiology. Norsk Epidemiologi. 5-6.
  • Vis forfatter(e) (2021). The Inverse Association of Body Mass Index with Lung Cancer: Exploring Residual Confounding, Metabolic Aberrations and Within-Person Variability in Smoking. Cancer Epidemiology, Biomarkers and Prevention. 1489-1497.
  • Vis forfatter(e) (2021). Prescribed drugs in 27 000 individuals after diagnosis of colorectal cancer: A population-based cohort study. Pharmacoepidemiology and Drug Safety. 1037-1048.
  • Vis forfatter(e) (2021). Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project. International Journal of Cancer. 66-74.
  • Vis forfatter(e) (2021). Male to female ratios in autism spectrum disorders by age, intellectual disability and attention-deficit/hyperactivity disorder. Acta Psychiatrica Scandinavica. 635-646.
  • Vis forfatter(e) (2020). Validation of assisted reproductive technology in the Medical Birth Registry of Norway versus the Norwegian Prescription Database. Epidemiology. 681-686.
  • Vis forfatter(e) (2020). Urinary incontinence associated with anxiety and depression: the impact of psychotropic drugs in a cross-sectional study from the Norwegian HUNT study. BMC Psychiatry. 1-10.
  • Vis forfatter(e) (2020). Sex differences in parent–offspring recurrence of attention-deficit/hyperactivity disorder. Journal of Child Psychology and Psychiatry. 1-9.
  • Vis forfatter(e) (2020). Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study. British Journal of Cancer. 161-166.
  • Vis forfatter(e) (2020). Medfødte misdannelser gir økt risiko for kreft. Aftenposten Viten. 24-25.
  • Vis forfatter(e) (2020). Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study. The Lancet Diabetes and Endocrinology. 94-105.
  • Vis forfatter(e) (2020). Incidence of Malformations After Early Pregnancy Exposure to Modafinil in Sweden and Norway. Journal of the American Medical Association (JAMA). 895-896.
  • Vis forfatter(e) (2020). Cancer risk in individuals with major birth defects: large Nordic population based case-control study among children, adolescents, and adults. The BMJ. 14 sider.
  • Vis forfatter(e) (2020). Antipsychotic drug use in pregnancy: A multinational study from ten countries. Schizophrenia Research. 106-115.
  • Vis forfatter(e) (2019). The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. International Journal of Epidemiology. 93-104.
  • Vis forfatter(e) (2019). Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway. Pharmacology Research & Perspectives. 1-10.
  • Vis forfatter(e) (2019). Patterns of psychiatric comorbidity and genetic correlations provide new insights into differences between attention-deficit/hyperactivity disorder and autism spectrum disorder. Biological Psychiatry. 46 sider.
  • Vis forfatter(e) (2019). Parent-offspring recurrence of attention-deficit/hyperactivity disorder.
  • Vis forfatter(e) (2019). Parent-offspring recurrence of ADHD.
  • Vis forfatter(e) (2019). Linear age-course effects on the associations between body mass index, triglycerides, and female breast and male liver cancer risk: An internal replication study of 800,000 individuals. International Journal of Cancer. 58-67.
  • Vis forfatter(e) (2019). Epilepsy and autoimmune diseases: Comorbidity in a national patient cohort. Seizure. 89-95.
  • Vis forfatter(e) (2019). BMI and weight changes and risk of obesity-related cancers: a pooled European cohort study. International Journal of Epidemiology. 1872-1885.
  • Vis forfatter(e) (2019). Associations of pregnancy-related factors and birth characteristics with risk of endometrial cancer: A Nordic population-based case-control study. International Journal of Cancer. 1-10.
  • Vis forfatter(e) (2018). Urate and the risk of Parkinson's disease in men and women. Parkinsonism & Related Disorders. 76-82.
  • Vis forfatter(e) (2018). Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiology and Drug Safety. 995-1004.
  • Vis forfatter(e) (2018). Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Vis forfatter(e) (2018). Psychiatric comorbidity and genetic correlations provide new insights into differences between ADHD and autism .
  • Vis forfatter(e) (2018). Psychiatric comorbidities in adults with ADHD and/or autism: Can patterns of comorbidities together with genetics add knowledge on etiologic relations? .
  • Vis forfatter(e) (2018). Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. International Journal of Cancer. 1858-1867.
  • Vis forfatter(e) (2018). Pregnancy complications and subsequent breast cancer risk in the mother: a Nordic population-based case-control study. International Journal of Cancer. 1904-1913.
  • Vis forfatter(e) (2018). Oral Fluconazole in Pregnancy and Risk of Stillbirth and Neonatal Death. Journal of the American Medical Association (JAMA). 2333-2335.
  • Vis forfatter(e) (2018). Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 1286-1294.
  • Vis forfatter(e) (2018). Diabetes is associated with decreased migraine risk: A nationwide cohort study. Cephalalgia. 1759-1764.
  • Vis forfatter(e) (2018). Beta-blocker use in pregnancy and the risk of congenital malformations: An international cohort study. Annals of Internal Medicine. 665-673.
  • Vis forfatter(e) (2017). beta(2)-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease. Science. 891-897.
  • Vis forfatter(e) (2017). The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. European Journal of Clinical Pharmacology. 513-520.
  • Vis forfatter(e) (2017). Psychiatric comorbidities in male and female adults with ADHD.
  • Vis forfatter(e) (2017). Preterm births and use of medication in early adulthood: a population-based registry study. Pharmacoepidemiology and Drug Safety. 742-751.
  • Vis forfatter(e) (2017). OMT or drug abuse during pregnancy - does it affect the offspring? Results from Nationwide registry studies in the Czech Republic and Norway.
  • Vis forfatter(e) (2017). Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study. The BMJ. 8 sider.
  • Vis forfatter(e) (2017). Neonatal Outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
  • Vis forfatter(e) (2017). Gender differences in psychiatric comorbidity: a population-based study of 40 000 adults with attention deficit hyperactivity disorder. Acta Psychiatrica Scandinavica. 176-186.
  • Vis forfatter(e) (2017). Gender Differences in Psychiatric Comorbidity: A Population-based Study of 40,000 Adults with Attention-Deficit/Hyperactivity Disorder.
  • Vis forfatter(e) (2017). Correction to: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-1.
  • Vis forfatter(e) (2017). Condition of newborns of women received OMT and opiates during pregnancy: comparison of Czech and Norwegian cohorts.
  • Vis forfatter(e) (2017). Cohort Profile Update: The Janus Serum Bank Cohort in Norway. International Journal of Epidemiology. 1101-1102f.
  • Vis forfatter(e) (2017). Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological Psychiatry. 452-459.
  • Vis forfatter(e) (2017). Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study. European Child and Adolescent Psychiatry. 1-13.
  • Vis forfatter(e) (2017). Association between methylphenidate and amphetamine use in pregnancy and risk of congenital malformations: A cohort study from the international pregnancy safety study consortium. JAMA psychiatry. 167-175.
  • Vis forfatter(e) (2016). Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants in pregnancy and congenital anomalies: Analysis of linked databases in Wales, Norway and Funen, Denmark. PLOS ONE. 26 sider.
  • Vis forfatter(e) (2016). Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy – a cohort linkage study. BJOG: An International Journal of Obstetrics and Gynaecology. 1609-1618.
  • Vis forfatter(e) (2016). Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case–control study. British Journal of Cancer. 1416-1420.
  • Vis forfatter(e) (2016). Psychotropic Drug Exposure and Hip Fractures.
  • Vis forfatter(e) (2016). Prescribing of antidiabetic medicines before, during and after pregnancy: A study in seven European regions. PLOS ONE. 17 sider.
  • Vis forfatter(e) (2016). Pre-eclampsia and childhood asthma. European Respiratory Journal. 1622-1630.
  • Vis forfatter(e) (2016). Educational attainment among long-term survivors of cancer in childhood and adolescence: a Norwegian population-based cohort study. Journal of cancer survivorship. 87-95.
  • Vis forfatter(e) (2016). Does the choice of antiepileptic drug affect survival in glioblastoma patients? Journal of Neuro-Oncology. 461-469.
  • Vis forfatter(e) (2016). Asthma medication prescribing before, during and after pregnancy: a study in seven European regions. BMJ Open. 13 sider.
  • Vis forfatter(e) (2016). Antipsychotic drugs and risk of hip fracture among people older than 60 years in Norway. Journal of The American Geriatrics Society. 1203-1209.
  • Vis forfatter(e) (2015). Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG: An International Journal of Obstetrics and Gynaecology. 1618-1624.
  • Vis forfatter(e) (2015). Social inequalities and smoking-associated breast cancer - Results from a prospective cohort study. Preventive Medicine. 125-129.
  • Vis forfatter(e) (2015). Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: Population based cohort study and sibling design. The BMJ.
  • Vis forfatter(e) (2015). Risk of hip fracture among older people using antihypertensive drugs: a nationwide cohort study. BMC Geriatrics. 1-10.
  • Vis forfatter(e) (2015). Preeclampsia in pregnancy and later use of antihypertensive drugs. European Journal of Epidemiology (EJE). 501-508.
  • Vis forfatter(e) (2015). Metabolic risk score and cancer risk: pooled analysis of seven cohorts. International Journal of Epidemiology. 1353-1363.
  • Vis forfatter(e) (2015). Antiepileptic drug prescribing before, during and after pregnancy: a study in seven European regions. Pharmacoepidemiology and Drug Safety. 1144-1154.
  • Vis forfatter(e) (2014). Total drug treatment and comorbidity in myasthenia gravis: A population-based cohort study. European Journal of Neurology. 948-955.
  • Vis forfatter(e) (2014). The Association between Lifetime Smoking Exposure and Breast Cancer Mortality – Results from a Norwegian Cohort. Cancer Medicine. 1448-1457.
  • Vis forfatter(e) (2014). Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. European Journal of Clinical Pharmacology. 873-880.
  • Vis forfatter(e) (2014). Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a 6-year follow-up study based on nationwide registries.
  • Vis forfatter(e) (2014). Prostate cancer, prostate cancer death, and death from other causes, among men with metabolic aberrations. Epidemiology. 823-828.
  • Vis forfatter(e) (2014). Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Vis forfatter(e) (2014). Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries. Acta Neurologica Scandinavica. 26-31.
  • Vis forfatter(e) (2014). Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: A prospective study of 580 000 subjects within the Me-Can project. BMC Cancer. 12 sider.
  • Vis forfatter(e) (2014). Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation. Acta Obstetricia et Gynecologica Scandinavica. 647-653.
  • Vis forfatter(e) (2014). Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: a population-based cohort study. European Journal of Clinical Pharmacology. 1367-1374.
  • Vis forfatter(e) (2014). Associations between hip fractures & psychotropic drugs - a Nationwide prospective cohort study.
  • Vis forfatter(e) (2014). A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study. PLOS ONE.
  • Vis forfatter(e) (2013). Total serum cholesterol and cancer incidence in the Metabolic Syndrome and Cancer Project (Me-Can). PLOS ONE. 8 sider.
  • Vis forfatter(e) (2013). Smoking duration before first childbirth: an emerging risk factor for breast cancer? Results from 302,865 Norwegian women. Cancer Causes and Control. 1347-1356.
  • Vis forfatter(e) (2013). Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. Journal of the American Medical Association (JAMA). 48-54.
  • Vis forfatter(e) (2013). Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination. New England Journal of Medicine. 333-340.
  • Vis forfatter(e) (2013). Risk of Fetal Death After Pandemic Influenza Virus Infection or Vaccination EDITORIAL COMMENT. Obstetrical and Gynecological Survey. 348-349.
  • Vis forfatter(e) (2013). Prospective cohort study of metabolic risk factors and gastric adenocarcinoma risk in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 107-116.
  • Vis forfatter(e) (2013). Prescription drug use among pregnant women in opioid Maintenance Treatment. Addiction. 367-376.
  • Vis forfatter(e) (2013). Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes and Control. 151-159.
  • Vis forfatter(e) (2013). Metabolic Factors Associated with Risk of Renal Cell Carcinoma. PLOS ONE.
  • Vis forfatter(e) (2013). Increased uptake of social security benefits among long-term survivors of cancer in childhood, adolescence and young adulthood: a Norwegian population-based cohort study. British Journal of Cancer. 1525-1533.
  • Vis forfatter(e) (2013). Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age and Ageing. 514-520.
  • Vis forfatter(e) (2013). Hip fracture and use of antidepressant drugs.
  • Vis forfatter(e) (2013). Fetal growth and childhood cancer: A population-based study. Pediatrics. E1265-E1275.
  • Vis forfatter(e) (2013). Effects of preconceptional paternal drug exposure on birth outcomes: cohort study of 340,000 pregnancies using Norwegian population-based databases. British Journal of Clinical Pharmacology. 1134-1141.
  • Vis forfatter(e) (2012). The 2009 Influenza Pandemic, Vaccination during Pregnancy and Fetal Death: A National Registry-Based Study in Norway. Pharmacoepidemiology and Drug Safety. 382-382.
  • Vis forfatter(e) (2012). Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ. British Medical Journal. 9 sider.
  • Vis forfatter(e) (2012). Prospective study on metabolic factors and risk of prostate cancer. Cancer. 6199-6206.
  • Vis forfatter(e) (2012). Prescription Drug Use among Pregnant Women in Opioid Maintenance Treatment. Pharmacoepidemiology and Drug Safety. 388-388.
  • Vis forfatter(e) (2012). Prescribing quality for older people in Norwegian nursing homes and home nursing services using multidose dispensed drugs. Pharmacoepidemiology and Drug Safety. 929-936.
  • Vis forfatter(e) (2012). Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers. Scandinavian Journal of Rheumatology. 196-201.
  • Vis forfatter(e) (2012). Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can). British Journal of Dermatology. 59-67.
  • Vis forfatter(e) (2012). Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. International Journal of Cancer. 193-200.
  • Vis forfatter(e) (2012). Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can). Gynecologic Oncology. 330-335.
  • Vis forfatter(e) (2012). Metabolic factors and blood cancers among 578,000 adults in the metabolic syndrome and cancer project (Me-Can). Annals of Hematology. 1519-1531.
  • Vis forfatter(e) (2012). Increased hip fracture risk in older persons exposed to antidepressant drugs.
  • Vis forfatter(e) (2012). Inappropriate prescribing for older people admitted to an intermediate-care nursing home unit and hospital wards. Scandinavian Journal of Primary Health Care. 169-175.
  • Vis forfatter(e) (2012). Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential. Clinical Pharmacology and Therapeutics. 438-441.
  • Vis forfatter(e) (2012). Co-prescription of medication for bipolar disorder and diabetes mellitus: A nationwide population-based study. BMC Medicine. 6 sider.
  • Vis forfatter(e) (2012). Blood pressure and risk of cancer incidence and mortality in the Metabolic syndrome and cancer project. Hypertension. 802-810.
  • Vis forfatter(e) (2012). Blood pressure and other metabolic syndrome factors and risk of brain tumor in the large population-based Me-Can cohort study. Journal of Hypertension. 290-296.
  • Vis forfatter(e) (2012). An increased risk of motor vehicle accidents after prescription of methadone. Addiction. 967-972.
  • Vis forfatter(e) (2012). Increased hip fracture risk in older persons exposed to antidepressant drugs.
  • Vis forfatter(e) (2011). Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: a population-based cohort study. European Journal of Clinical Pharmacology. 953-960.
  • Vis forfatter(e) (2011). Use of Legally Prescribed Opioid Analgesics in Pregnant Women and Risk of Spontaneous Preterm Birth. A Population Based Cohort Study, Norway 2004-2008. Pharmacoepidemiology and Drug Safety. S75-S75.
  • Vis forfatter(e) (2011). USE OF PRESCRIBED DRUGS FOR THE NERVOUS SYSTEM AMONG WOMEN IN OPIOID MAINTENANCE TREATMENT BEFORE AND DURING PREGNANCY IN NORWAY, 2004-2008. Drug and Alcohol Review. 57-57.
  • Vis forfatter(e) (2011). Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes and Control. 291-299.
  • Vis forfatter(e) (2011). Risk of diabetes after gestational diabetes and preeclampsia. A registry-based study of 230,000 women in Norway. European Journal of Epidemiology (EJE). 157-163.
  • Vis forfatter(e) (2011). Prescribing quality for older people in nursing homes and home care services using multi-dose dispensed drugs.
  • Vis forfatter(e) (2011). Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). International Journal of Cancer. 1890-1898.
  • Vis forfatter(e) (2011). Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Annals of Oncology. 1339-1345.
  • Vis forfatter(e) (2011). Metabolic risk factors and ovarian cancer in the Metabolic syndrome and cancer project. International Journal of Epidemiology. 1667-1677.
  • Vis forfatter(e) (2011). Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes and Control. 743-751.
  • Vis forfatter(e) (2011). Metabolic Factors and the Risk of Colorectal Cancer in 580,000 Men and Women in the Metabolic Syndrome and Cancer Project (Me-Can). Cancer. 2398-2407.
  • Vis forfatter(e) (2011). Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database. Pharmacoepidemiology and Drug Safety. 243-248.
  • Vis forfatter(e) (2011). An increased risk of road traffic accidents after prescriptions of methadone. Addiction.
  • Vis forfatter(e) (2010). Myasthenia gravis requiring pyridostigmine treatment in a national population cohort. European Journal of Neurology. 1445-1450.
  • Vis forfatter(e) (2010). Metabolic syndrome and endometrial carcinoma. American Journal of Epidemiology. 892-902.
  • Vis forfatter(e) (2010). Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project. Cancer Epidemiology, Biomarkers and Prevention. 1737-1745.
  • Vis forfatter(e) (2010). Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. Cancer Epidemiology, Biomarkers and Prevention. 2307-2317.
  • Vis forfatter(e) (2010). Does Pregabalin (Lyrica (R)) help patients reduce their use of Benzodiazepines? A comparison with gabapentin using the norwegian prescription database. Basic & Clinical Pharmacology & Toxicology. 883-886.
  • Vis forfatter(e) (2010). Cohort Profile: The Metabolic syndrome and Cancer project (Me-Can). International Journal of Epidemiology. 660-667.
  • Vis forfatter(e) (2009). Validation of disease registration in pregnant women in the Medical Birth Registry of Norway. Acta Obstetricia et Gynecologica Scandinavica. 1083-1089.
  • Vis forfatter(e) (2009). Use of opioids in mothers and fathers before and during pregnancy-2004-2006. Pharmacoepidemiology and Drug Safety. S71-S72.
  • Vis forfatter(e) (2009). Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study. Pharmacoepidemiology and Drug Safety. 737-742.
  • Vis forfatter(e) (2009). The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007-A prescription database study. Journal of Affective Disorders. 208-211.
  • Vis forfatter(e) (2009). The risk of motor vehicle accidents involving drivers with prescriptions for codeine or tramadol. Clinical Pharmacology and Therapeutics. 596-599.
  • Vis forfatter(e) (2009). Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. European Journal of Clinical Pharmacology. 295-301.
  • Vis forfatter(e) (2009). Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study. Diabetic Medicine. 404-408.
  • Vis forfatter(e) (2009). Myasthenia gravis requiring drug treatment in a national population cohort. European Journal of Neurology. S207.
  • Vis forfatter(e) (2009). Fetal down syndrome and the risk of maternal breast cancer. Epidemiology. 584-589.
  • Vis forfatter(e) (2009). An increased risk of road traffic accidents after prescriptions of lithium or valproate? Pharmacoepidemiology and Drug Safety. 492-496.
  • Vis forfatter(e) (2008). Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie. Norsk Epidemiologi. 159-165.
  • Vis forfatter(e) (2008). Use of antirheumatic drugs in mothers and fathers before and during pregnancy, 2004-2006. Pharmacoepidemiology and Drug Safety. S158.
  • Vis forfatter(e) (2008). Use of antirheumatic drugs in mothers and fathers before and during pregnancy. Annals of the Rheumatic Diseases. 581-581.
  • Vis forfatter(e) (2008). The use of lithium, valproate or lamotrigine as mood stabilizers in children and adolescents in Norway 2004-2007. Pharmacoepidemiology and Drug Safety. S90-S91.
  • Vis forfatter(e) (2008). Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Medicine. 818-822.
  • Vis forfatter(e) (2008). Repeated dispensing of codeine is associated with high consumption of benzodiazepines. Norsk Epidemiologi. 185-190.
  • Vis forfatter(e) (2008). Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004-2006. British Journal of Clinical Pharmacology. 653-660.
  • Vis forfatter(e) (2008). Patients treated with insulin or oral blood glucose lowering drugs and risk of road traffic accidents: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S190.
  • Vis forfatter(e) (2008). No increase in risk of road traffic accidents after prescriptions of mood stabilizers. Pharmacoepidemiology and Drug Safety. S19-S20.
  • Vis forfatter(e) (2008). Minor increase in risk of road traffic accidents after prescriptions of antidepressants: A study of population registry data in Norway. Journal of Clinical Psychiatry. 1099-1103.
  • Vis forfatter(e) (2008). Cohort Profile: Cohort of Norway (CONOR). International Journal of Epidemiology. 481-485.
  • Vis forfatter(e) (2008). Changes in physical activity behavior and the development of body mass index during the last 30 years in Norway. Scandinavian Journal of Medicine & Science in Sports. 309-317.
  • Vis forfatter(e) (2008). Cancer risk in children with birth defects and in their families: A population based cohort study of 5.2 million children from Norway and Sweden. Cancer Epidemiology, Biomarkers and Prevention. 500-506.
  • Vis forfatter(e) (2008). Body mass index in adolescence in relation to cause-specific mortality: A follow-up of 230,000 Norwegian adolescents. American Journal of Epidemiology. 30-37.
  • Vis forfatter(e) (2008). Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. British Journal of Cancer. 1165-1169.
  • Vis forfatter(e) (2007). Veitrafikkulykker knyttet til forskrivning av legemidler: En registerbasert kohortstudie.
  • Vis forfatter(e) (2007). Use of stimulants for ADHD among children and adolescents in Norway: - a population based study 2004-2006.
  • Vis forfatter(e) (2007). Traffic accident risks associated with the prescription of medicinal drugs: A registry-based cohort study. Pharmacoepidemiology and Drug Safety. S12.
  • Vis forfatter(e) (2007). Traffic accident risk associated with the prescription of hypnotic drugs: a registry-based cohort study.
  • Vis forfatter(e) (2007). The risk of traffic accidents after prescriptions of carisoprodol. Accident Analysis and Prevention. 1050-1055.
  • Vis forfatter(e) (2007). Risk of road traffic accidents associated with the prescription of drugs: A registry-based cohort study. Annals of Epidemiology. 597-602.
  • Vis forfatter(e) (2007). Psychostimulant use among children and adolescents with ADHD in Norway: a population based study 2004-2006.
  • Vis forfatter(e) (2007). Psychostimulant use among children and adolescents with ADHD in Norway: A population based study 2004-2006. Pharmacoepidemiology and Drug Safety.
  • Vis forfatter(e) (2007). Prescription drug use before, during and after pregnancy among 50,000 women in Norway in 2004-2005. Pharmacoepidemiology and Drug Safety.
  • Vis forfatter(e) (2007). Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Vis forfatter(e) (2007). Prescription drug use before, during and after pregnancy among 50 000 women in Norway in 2004-2005.
  • Vis forfatter(e) (2007). Medikamentbruk i forbindelse med svangerskap.
  • Vis forfatter(e) (2007). Medikamentbruk i forbindelse med svangerskap.
  • Vis forfatter(e) (2007). Height and body mass index and risk of lymphohematopoietic malignancies in two million norwegian men and women. American Journal of Epidemiology. 44-52.
  • Vis forfatter(e) (2007). Carisoprodol use and abuse in Norway. A pharmacoepidemiological study. British Journal of Clinical Pharmacology. 210-218.
  • Vis forfatter(e) (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. International Journal of Cancer. 378-383.
  • Vis forfatter(e) (2007). Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. BMC Clinical Pharmacology.
  • Vis forfatter(e) (2007). Antidepressiver hos barn og ungdom - førte advarsler til færre forskrivninger? Tidsskrift for Den norske legeforening. 2653-2655.
  • Vis forfatter(e) (2007). Age- and gender-specific antibacterial prescribing in Norway. Journal of Antimicrobial Chemotherapy. 971-976.
  • Vis forfatter(e) (2006). The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Vis forfatter(e) (2006). The prevalence and incidence of drug treated bipolar disorder in the adult(20-65 years) as seen in the Norwegian prescription database.
  • Vis forfatter(e) (2006). The pharmacoepidemiology of carisoprodol misuse and abuse.
  • Vis forfatter(e) (2006). The pharmacoepidemiology of Carisoprodol misuse and abuse. Pharmacoepidemiology and Drug Safety. S112-S113.
  • Vis forfatter(e) (2006). The impact of medicinal authority's warnings on the prescribing of SSRI antidepressants to children and adolescents in Norway. Pharmacoepidemiology and Drug Safety. S211-S211.
  • Vis forfatter(e) (2006). The impact of height and body mass index on the risk of testicular cancer in 600,000 Norwegian men. Cancer Causes and Control. 983-987.
  • Vis forfatter(e) (2006). The impact of body mass index on later total hip arthroplasty for primary osteoarthritis - A cohort study in 1.2 million persons. Arthritis and Rheumatism. 802-807.
  • Vis forfatter(e) (2006). The Impact of Medicinal Authority's Warnings on the Prescribing of SSRI Antidepressants to Children and Adolescents in Norway.
  • Vis forfatter(e) (2006). Hvor mange og hvem behandles medikamentelt for diabetes mellitus? Tidsskrift for Den norske legeforening. 768-770.
  • Vis forfatter(e) (2006). How many and who are receiving medication for treatment of diabetes mellitus in Norway? Pharmacoepidemiology and Drug Safety. S162-S162.
  • Vis forfatter(e) (2006). How many and who are receiving medication for treatment of diabetes mellitus in Norway?
  • Vis forfatter(e) (2006). Endringer i salg og bruk av flunitrazepam etter 1999. Tidsskrift for Den norske legeforening. 589-590.
  • Vis forfatter(e) (2006). Comparison of statin use in three Norwegian counties in 2004- an individualised prescription database study.
  • Vis forfatter(e) (2006). Comparison of statin use in three Norwegian counties in 2004 - An individualised prescription database study. Pharmacoepidemiology and Drug Safety. S256-S256.
  • Vis forfatter(e) (2006). Body size and thyroid cancer in two million Norwegian men and women. British Journal of Cancer. 366-370.
  • Vis forfatter(e) (2006). Age and sex specific antibacterial prescribing in Norway. Pharmacoepidemiology and Drug Safety. S69-S69.
  • Vis forfatter(e) (2005). The Norwegian prescription database(NorPD)-a new register for pharmacoepidemiologic research covering a whole nation.
  • Vis forfatter(e) (2005). Height and body mass index in relation to colorectal and gallbladder cancer in two million Norwegian men and women. Cancer Causes and Control. 987-996.
  • Vis forfatter(e) (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Vis forfatter(e) (2005). Height and body mass index in relation to cancer of the small intestine in two million Norwegian men and women. British Journal of Cancer. 807-810.
  • Vis forfatter(e) (2005). Do variations in sales of lipid-lowering drugs reflect true prevalences of use?A prescription database study of lipid-lowering drugs in regions with high (Hedmark), average (Oppland) and low (Troms) total sales.
  • Vis forfatter(e) (2004). Relation of Height and Body Mass Index to Renal Cell Carcinoma in Two Million Norwegian Men and Women. American Journal of Epidemiology. 1168-1176.
  • Vis forfatter(e) (2004). Obesity in adolescence and adulthood and the risk of adult mortality. Epidemiology. 79-85.
  • Vis forfatter(e) (2004). Body mass index in relation to adult asthma among 135,000 Norwegian men and women. American Journal of Epidemiology. 169-976.
  • Vis forfatter(e) (2003). Height, body mass index and prostate cancer: a follow-up of 950 000 Norwegian men. British Journal of Cancer. 1237-1242.
  • Vis forfatter(e) (2003). Height, body mass index and ovarian cancer: a follow-up of 1.1 million Norwegian women. Journal of the National Cancer Institute. 1244-1248.
  • Vis forfatter(e) (2003). Er det forskjeller i forekomst av underarmsbrudd mellom by og land i Norge? Data fra CONOR.
  • Vis forfatter(e) (2003). CONOR (Cohort NORway) - en oversikt over en unik forskningdata. Norsk Epidemiologi. 72-77.
  • Vis forfatter(e) (2003). Body mass index in adolescence in relation to total mortality: 32 year follow-up 227, Norwegian and girls. American Journal of Epidemiology. 517-523.
  • Vis forfatter(e) (2003). A height and body mass index in relation to total mortality. Epidemiology. 293-299.
  • Vis forfatter(e) (2002). Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. British Journal of Cancer. 61-64.
  • Vis forfatter(e) (2002). Effects of first aid training in junior high schools. Injury control and safety promotion. 99-106.
  • Vis forfatter(e) (2002). Bruk av p-piller og risiko for kreft. Tidsskrift for Den norske legeforening. 1788-1790.
  • Vis forfatter(e) (2001). Serum-albumin and risk of thyroid cancer: A population-based, matched case-control study. Norsk Epidemiologi. 197-200.
  • Vis forfatter(e) (2000). Impact of Safe Community program in Harstad on incidence of injuries. Injury control and safety promotion. 29-39.
  • Vis forfatter(e) (2000). Hjemmeulykker blant småbarn og potensialet for forebygging. Tidsskrift for Den norske legeforening. 3376-3379.
  • Vis forfatter(e) (1999). Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: A matched case control study. Thyroid. 285-288.
  • Vis forfatter(e) (1999). Screening mot kreft. Tidsskrift for Den norske legeforening. 1129-1136.
  • Vis forfatter(e) (1998). Prognosis of patients with Ovarian Cancer and Borderline Tumours Diagnosed in Norway between 1954 and 1993. International Journal of Cancer. 663-670.
  • Vis forfatter(e) (1998). Prognosis of 2.800 patients with epithelial ovarian cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Acta Obstetricia et Gynecologica Scandinavica. 777-781.
  • Vis forfatter(e) (1998). Ovarialcancer og borderlinetumorer. Tidsskrift for Den norske legeforening. 2471-2475.
  • Vis forfatter(e) (1998). Ovarialcancer og borderlinetumorer. Tidsskrift for Den norske legeforening. 2471-2475.
  • Vis forfatter(e) (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-93. Acta Obstetricia et Gynecologica Scandinavica. 606.
  • Vis forfatter(e) (1997). Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993. International Journal of Cancer. 780-786.
  • Vis forfatter(e) (1997). Smoking-associated cancers in Norway.
  • Vis forfatter(e) (1997). Serumproteiner hos pasienter med nyoppdaget kreft i munnhule/svelg. Hvilken lærdom gav konsentrasjonsmåling og elektroforese? Tidsskrift for Den norske legeforening. 3671-3673.
  • Vis forfatter(e) (1997). Provocative appe4als in anti-smoking a mass media campaigns targeting adolescents - the accumulated effect of multiple exposure. Health Education Research. 227-236.
  • Vis forfatter(e) (1997). Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ. British Medical Journal. 646-649.
  • Vis forfatter(e) (1997). Prognosis of 3,000 Patients with Epithelial Ovarian Cancer diagnosed during 1975-94 and treated at the Norwegian Radium Hospital. Society of Pelvic Surgeons: Forty-seventh annual meeting. 35.
  • Vis forfatter(e) (1997). Ovarian Cancer-Are we making progress? European Journal of Cancer. 621.
  • Vis forfatter(e) (1997). A Prospective, Seroepidemiological Study of the Role of Human Papillomavirus in Esophageal Cancer in Norway. Cancer Research. 3989-3992.

Se fullstendig oversikt over publikasjoner i CRIStin.

  • Medikamentbruk i forbindelse med svangerskap

  • Legemiddelbruk blant kreftpasienter
  • Metabolsk syndrom og kreft

  • Forhold under graviditet og fødselskarakteristika i relasjon til kreft blant barn og ungdom
  • Kreftrisiko i familier med barn med medfødte misdannelser

 

Cand. Scient. (matematisk statistikk)

Dr. philos. i kreftepidemiologi